Longevity & AgingResearch PaperOpen Access

Exercise and IgG Glycosylation Show No Strong Link in Young Medical Students

A cross-sectional study finds self-reported physical activity is not robustly associated with IgG N-glycan profiles in young adults.

Saturday, June 20, 2026 1 views
Published in Croat Med J
Close-up molecular illustration of a biantennary IgG glycan structure glowing faintly, beside a silhouette of a student jogging on a university campus.

Summary

Researchers measured IgG N-glycosylation patterns — molecular markers of immune inflammation — in 79 medical students and compared results against self-reported physical activity levels. Using the validated IPAQ-SF questionnaire, students were classified as health-enhancing physical activity (HEPA)-active or not. While a few weak correlations appeared between vigorous or total activity and galactosylation markers (G1, G2) in unadjusted analyses, none survived multiple-testing correction. HEPA-active and non-HEPA-active groups showed no significant differences in any of the 27 individual glycan peaks or 8 derived glycan traits. The findings suggest that in this young, generally healthy, homogeneous population, everyday physical activity does not meaningfully reshape the IgG glycome.

Detailed Summary

IgG N-glycosylation is increasingly recognized as a sensitive molecular readout of systemic immune and inflammatory status. Specific glycan features — particularly low galactosylation and sialylation — track with aging, chronic disease, and pro-inflammatory states, while higher galactosylation and sialylation reflect a more anti-inflammatory phenotype. Because regular physical activity (PA) broadly reduces low-grade inflammation, researchers hypothesized that habitual PA might be detectable at the level of IgG glycan composition, even in young, healthy individuals.

This cross-sectional study enrolled 79 first- and second-year medical students (56 women; median age 20 years) at the University Josip Juraj Strossmayer in Osijek, Croatia. PA was assessed via the validated International Physical Activity Questionnaire – Short Form (IPAQ-SF), capturing walking, moderate, and vigorous activity, total MET-min/week, and sitting time. Participants were classified as HEPA-active (n=23) or non-HEPA-active (n=56). IgG was isolated from plasma and N-glycans profiled using capillary gel electrophoresis with laser-induced fluorescence detection (CGE-LIF), quantifying 27 glycan peaks and 8 derived structural traits (G0, G1, G2, S0, S1, S2, bisecting GlcNAc, and core fucosylation).

The two PA groups showed no statistically significant differences across any of the 27 individual glycan peaks or 8 derived traits after Benjamini-Hochberg false discovery rate correction (all FDR-adjusted P = 0.893). In unadjusted correlation analyses, modest associations emerged: vigorous PA correlated weakly with G1 (ρ = 0.24, P = 0.034), and total PA correlated with G1 (ρ = 0.27, P = 0.017) and negatively with G2 (ρ = −0.34, P = 0.002). However, none of these passed multiple-testing correction. BMI-adjusted partial Spearman correlations and interaction analyses did not reveal meaningful effect modification.

The authors attribute the null findings to several factors: the population is young, relatively healthy, and metabolically homogeneous, which narrows the biological range over which PA-related glycan variation could manifest. The mandatory PA curriculum at the medical school also likely compressed inter-individual PA differences. Self-reported PA via IPAQ-SF introduces measurement error, and the cross-sectional design cannot capture cumulative or dose-dependent effects over time. The sample size of 79 also limits statistical power.

These results temper expectations that short-term or moderate differences in habitual PA are readily detectable in the IgG glycome of young adults. Prior research suggesting PA-glycan links has largely focused on older adults, clinical populations, or structured athletic training — contexts where physiological contrasts are much larger. The study provides a useful null-result benchmark, suggesting that glycan biomarkers of PA may only be detectable in more extreme or longitudinal exposure scenarios.

Key Findings

  • HEPA-active and non-HEPA-active students showed no significant differences in all 27 IgG N-glycan peaks or 8 derived traits.
  • Weak unadjusted correlations between total/vigorous PA and galactosylation (G1, G2) did not survive multiple-testing correction.
  • Over half of participants (70.9%) were classified as non-HEPA-active; 29.1% sat more than 10 hours daily.
  • BMI adjustment and interaction analyses did not reveal meaningful confounding or effect modification.
  • Findings suggest IgG glycan biomarkers may not capture moderate PA variation in young, healthy, homogeneous populations.

Methodology

Cross-sectional study of 79 medical students using the validated IPAQ-SF for self-reported PA assessment and CGE-LIF for quantification of 27 IgG N-glycan peaks and 8 derived glycan traits from EDTA plasma. Statistical analysis included Mann-Whitney U tests, Spearman correlations, partial correlations adjusted for BMI, and Benjamini-Hochberg FDR correction for multiple comparisons.

Study Limitations

The small, homogeneous sample (n=79) of young students limits statistical power and generalizability. Self-reported PA via IPAQ-SF is subject to recall and social desirability bias. The cross-sectional design cannot establish causality or capture cumulative lifetime PA effects on glycosylation.

Enjoyed this summary?

Get the latest longevity research delivered to your inbox every week.